A ProPublica analysis found that black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at a type of cancer that disproportionately affects them

Quick Read

Academic institutions are breaching rules by failing to report the results of clinical trials, new research shows. A study, published in journal BMJ, found “poor” compliance with EU regulations which require outcomes to be posted to a central register within 12 months

Quick Read

David Dobbs writes, “An early halt to a trial of deep brain stimulation for depression reveals little about the treatment but more about the changing nature of clinical trials.”

Quick Read

David Gerber writes, “I couldn’t think of a single way in which the patient’s prior experience with cancer would interfere with treatments or assessments on a lung cancer trial. And yet I couldn’t enroll him…. Unfortunately, many sick patients are being denied the opportunity to test new drugs that might save their lives. It’s time for this to change.”

Quick Read

President Donald Trump’s likely pick to lead the Centers for Disease Control and Prevention is facing significant criticism because of a 20-year-old controversy over shoddy HIV research

Quick Read

Clinical trial will compare three antiretroviral drug regimens. It will provide data on the use of these newer drugs during pregnancy, helping to ensure that women living with HIV and their infants receive the best available treatments

Quick Read

Holly Fernandez Lynch writes, “Nevertheless, even the upswing still leaves quite a bit of the glass empty: Results from more than 1 in 4 trials have still not been properly reported. The ethical consequences are substantial, and the government should be using its considerable enforcement authority to put an end to it. But it isn’t.”

Quick Read

The human immune system can hinder the gene-editing tool, though there could be ways around it

Quick Read